Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 6
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Immune checkpoint inhibitors and kidney disease.
Wang Q, Moledina DG, Sise ME. Wang Q, et al. Curr Opin Nephrol Hypertens. 2022 Sep 1;31(5):449-455. doi: 10.1097/MNH.0000000000000805. Epub 2022 Jul 11. Curr Opin Nephrol Hypertens. 2022. PMID: 35894279 Review.
Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis.
Moledina DG, Obeid W, Smith RN, Rosales I, Sise ME, Moeckel G, Kashgarian M, Kuperman M, Campbell KN, Lefferts S, Meliambro K, Bitzer M, Perazella MA, Luciano RL, Pober JS, Cantley LG, Colvin RB, Wilson FP, Parikh CR. Moledina DG, et al. J Clin Invest. 2023 Jul 3;133(13):e168950. doi: 10.1172/JCI168950. J Clin Invest. 2023. PMID: 37395276 Free PMC article.
APOBEC-1 deletion enhances cisplatin-induced acute kidney injury.
Guo X, Blanc V, Davidson NO, Velazquez H, Chen TM, Moledina DG, Moeckel GW, Safirstein RL, Desir GV. Guo X, et al. Sci Rep. 2023 Dec 14;13(1):22255. doi: 10.1038/s41598-023-49575-3. Sci Rep. 2023. PMID: 38097707 Free PMC article.
Longitudinal biomarkers and kidney disease progression after acute kidney injury.
Wen Y, Xu L, Melchinger I, Thiessen-Philbrook H, Moledina DG, Coca SG, Hsu CY, Go AS, Liu KD, Siew ED, Ikizler TA, Chinchilli VM, Kaufman JS, Kimmel PL, Himmelfarb J, Cantley LG, Parikh CR; ASSESS-AKI Consortium. Wen Y, et al. JCI Insight. 2023 May 8;8(9):e167731. doi: 10.1172/jci.insight.167731. JCI Insight. 2023. PMID: 36951957 Free PMC article.
The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Menez S, Wen Y, Xu L, Moledina DG, Thiessen-Philbrook H, Hu D, Obeid W, Bhatraju PK, Ikizler TA, Siew ED, Chinchilli VM, Garg AX, Go AS, Liu KD, Kaufman JS, Kimmel PL, Himmelfarb J, Coca SG, Cantley LG, Parikh CR. Menez S, et al. Kidney Int. 2023 Dec;104(6):1194-1205. doi: 10.1016/j.kint.2023.08.007. Epub 2023 Aug 29. Kidney Int. 2023. PMID: 37652206 Free article.
Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis.
Melchinger H, Calderon-Gutierrez F, Obeid W, Xu L, Shaw MM, Luciano RL, Kuperman M, Moeckel GW, Kashgarian M, Wilson FP, Parikh CR, Moledina DG. Melchinger H, et al. Clin J Am Soc Nephrol. 2022 Sep;17(9):1284-1292. doi: 10.2215/CJN.04360422. Epub 2022 Aug 10. Clin J Am Soc Nephrol. 2022. PMID: 35948365 Free PMC article.
Safety and Adequacy of Kidney Biopsy Procedure in Patients with Obesity.
Qian L, Menez S, Hu D, Weinstein J, Melchinger H, Thiessen-Philbrook H, Luciano RL, Turner JM, Perazella MA, Corona Villalobos CP, Shaw MM, Wilson FP, Parikh CR, Moledina DG. Qian L, et al. Kidney360. 2023 Jan 1;4(1):98-101. doi: 10.34067/KID.0006602022. Kidney360. 2023. PMID: 36700910 Free PMC article.
13 results